Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
PD Controller: Design01:26

PD Controller: Design

In automotive engineering, car suspension systems often employ Proportional Derivative (PD) controllers to enhance performance. PD controllers are utilized to adjust the damping force in response to road conditions. A controller, acting as an amplifier with a constant gain, demonstrates proportional control, with output directly mirroring input.
Designing a continuous-data controller requires selecting and linking components like adders and integrators, which are fundamental in Proportional,...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Psychoactive substance use and salivary periodontal pathogens among pregnant women in rural Rwanda.

Scientific reports·2026
Same author

Association between kidney function and risk of hyponatremia: a single-center, cross-sectional study in the outpatient setting.

Clinical and experimental nephrology·2026
Same author

Current status of assisted peritoneal dialysis in Japan: A nationwide questionnaire survey.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026
Same author

Facility-based educational systems and peritonitis incidence in peritoneal dialysis: findings from a nationwide survey in Japan.

Clinical and experimental nephrology·2026
Same author

Changes in mean corpuscular volume after erythropoiesis-stimulating agent treatment are associated with renal outcomes in non-dialysis-dependent chronic kidney disease.

Clinical and experimental nephrology·2026
Same author

Correction: Continuous glucose monitoring reveals periodontitis-induced glucose variability, insulin resistance, and gut microbiota dysbiosis in mice.

Scientific reports·2025

Related Experiment Video

Updated: May 22, 2026

Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease
07:21

Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease

Published on: June 16, 2023

Introduction and maintenance program for PD based on PD guidelines for Japan.

Masaaki Nakayama1

  • 1Fukushima Medical University School of Medicine, Department of Nephrology and Hypertension, Division of Dialysis Center, Fukushima, Japan.

Contributions to Nephrology
|May 23, 2012
PubMed
Summary

Japan's 2009 Peritoneal dialysis (PD) guidelines offer a framework for PD practice, emphasizing optimal timing for starting treatment and transitioning to other therapies. This review covers the guidelines and future considerations.

More Related Videos

Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults
09:19

Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults

Published on: December 9, 2014

Related Experiment Videos

Last Updated: May 22, 2026

Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease
07:21

Walk with Me Hybrid Virtual/In-Person Walking for Older Adults with Neurodegenerative Disease

Published on: June 16, 2023

Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults
09:19

Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults

Published on: December 9, 2014

Area of Science:

  • Nephrology
  • Renal Replacement Therapy

Background:

  • The Japanese Society for Dialysis Treatment established the first Peritoneal dialysis (PD) guidelines in 2009.
  • These guidelines provided a structured approach to PD practice in Japan.

Purpose of the Study:

  • To review the 2009 Japanese Peritoneal dialysis (PD) guidelines.
  • To highlight key aspects of PD introduction and modality transfer within the guidelines.
  • To identify areas for future development in PD care.

Main Methods:

  • Review of the 2009 Peritoneal dialysis (PD) guidelines published by the Japanese Society for Dialysis Treatment.
  • Analysis of the guidelines' recommendations on PD initiation and patient management.
  • Identification of future challenges and research directions in PD.

Main Results:

  • The 2009 guidelines established a clear framework for Peritoneal dialysis (PD) in Japan.
  • Emphasis was placed on the appropriate timing for initiating PD.
  • The guidelines addressed the clinical considerations for transferring patients to other dialysis modalities.

Conclusions:

  • The 2009 Japanese Peritoneal dialysis (PD) guidelines provided essential recommendations for clinical practice.
  • Further research and guideline updates are necessary to address evolving challenges in PD.
  • Optimizing PD introduction and modality selection remains crucial for patient outcomes.